The global Continuous Glucose Monitoring (CGM) Sensors market size was accounted at USD 3.6 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 18% from 2022 to 2030. Diabetes technology has progressed remarkably over the past few years, including the development of markers for diabetes control, sophisticated monitoring techniques, mathematical models, assessment procedures, and control algorithms.
Continuous glucose monitoring (CGM) sensors provide an effective approach in diabetes management as it checks glucose levels in real-time, displays the change in glucose levels. It also can be used as a tool to predict impending glucose excursions and to assess glycaemic variability. The clinical use of CGM also lowers the risk of mild to moderate hypoglycemia and eradicates the risk of severe and prolonged hypoglycemia.
These devices can be segregated as totally invasive, minimally invasive, and noninvasive based on the nature of their operation. Currently, automation of glucose monitoring is anticipated to save significant nursing time while improving glucose control and safety.
The Global Continuous Glucose Monitoring (CGM) Sensors market is expected to be driven mainly by the growing prevalence of Type 1 and Type 2 diabetes along with the growing geriatric population over the forecast period.
Furthermore, rapidly shifting consumer predilections toward an effective approach to manage diabetes, robust adoption of advanced diabetes management solutions in developing regions, favorable government policies, and rising healthcare spending over time across the globe, growing health awareness, increasing medical tourism, and easy affordability are key factors that are projected to further aid the market growth during the forecast period.
The Global Continuous Glucose Monitoring (CGM) Sensors Market is categorized on the basis of products, sensing technology, end-users, patient population, sites, and region.
On the basis of products, the market is segmented into non-invasive sensing and minimally invasive sensing. Based on sensing technology, the market is segmented into enzyme electrode, optical fluorescence, and others. On the basis of end-users, the market is segregated into hospitals and home care, specialty clinics, ambulatory settings, and others.
On the basis of patient population, the market is segmented into children & teenagers, and adults. Based on sensor sites, the market is categorized into abdomen, upper arm (implanted), back of upper arm, and other (abdomen and buttocks). Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.